A Study to Assess the Safety and Efficacy of ASP1941 in Combination With Dipeptidyl Peptidase-4 (DPP-4) Inhibitor in Type 2 Diabetic Patients
Clinical trial NCT01242228 · COMPLETED
Trial details
- NCT number
- NCT01242228
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-21
- Primary completion
- 2012-06-06
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.